Who has invested in Strata Oncology?

Pfizer, Merck are named among the investors backing Strata Oncology.

Strata Oncology Funding: $26M Raised, Series B (2018)

Strata Oncology funding overview

Strata Oncology is based in Ann Arbor. Strata Oncology has raised $26M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2018. The round record for Strata Oncology runs through 2018; nothing later has been disclosed. Investors on record include Pfizer, Merck. 2 distinct backers are named across the disclosed rounds.

Strata Oncology at a glance

Total raised: $26M
Latest round: Series B
Latest round date: January 2018
Headquarters: Ann Arbor
Notable investors: Pfizer, Merck

Frequently asked about Strata Oncology funding

How much has Strata Oncology raised?: Strata Oncology has raised $26M in total disclosed funding across the rounds on record.
Who has invested in Strata Oncology?: Pfizer, Merck are named among the investors backing Strata Oncology.
What was the latest Strata Oncology funding round?: The most recent disclosed round is a Series B, announced in January 2018.
Where is Strata Oncology based?: Strata Oncology is based in Ann Arbor.
When did Strata Oncology last raise?: The last disclosed Strata Oncology round closed in January 2018 at Series B.

Round data for Strata Oncology is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Ann Arbor and backer lists below.

Strata Oncology Funding: $26M Raised, Series B (2018)

Strata Oncology funding overview

Strata Oncology at a glance

Frequently asked about Strata Oncology funding

Companies related to Strata Oncology (28)

Browse related funding lists (5)